{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:27:55Z","timestamp":1787930875057,"version":"build-2784847793"},"reference-count":219,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10787-026-02328-w","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T01:20:41Z","timestamp":1783992041000},"page":"5423-5444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tau physiology and pathology: impacts on cellular structures and neurodegenerative diseases"],"prefix":"10.1007","volume":"34","author":[{"given":"Vali","family":"Akbari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seifollah","family":"Bahramikia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"2328_CR2","doi-asserted-by":"publisher","first-page":"108218","DOI":"10.1016\/j.abb.2019.108218","volume":"679","author":"V Akbari","year":"2020","unstructured":"Akbari V, Ghobadi S, Mohammadi S, Khodarahmi R (2020) The antidepressant drug; trazodone inhibits Tau amyloidogenesis: prospects for prophylaxis and treatment of AD. Arch Biochem Biophys 679:108218","journal-title":"Arch Biochem Biophys"},{"key":"2328_CR3","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.ijbiomac.2022.08.160","volume":"219","author":"V Akbari","year":"2022","unstructured":"Akbari V, Mohammadi S, Mehrabi M, Ghobadi S, Farrokhi A, Khodarahmi R (2022) Investigation of the role of prolines 232\/233 in RTPPK motif in tau protein aggregation: An in vitro study. Int J Biol Macromol 219:1100\u20131111","journal-title":"Int J Biol Macromol"},{"key":"2328_CR1","doi-asserted-by":"crossref","unstructured":"Akbari V, Bahramikia S, Jalalvand AR, Mehrabi M, Ezati M, Khodarahmi R (2023) The induction of tau aggregation is restricted by sulfamethoxazole and provides new information regarding the use of the drug. J Biomol Struct Dyn 1\u201315","DOI":"10.1080\/07391102.2023.2273433"},{"key":"2328_CR4","doi-asserted-by":"publisher","first-page":"151979","DOI":"10.1155\/2015\/151979","volume":"2015","author":"SM Alavi Naini","year":"2015","unstructured":"Alavi Naini SM, Soussi-Yanicostas N (2015) Tau hyperphosphorylation and oxidative stress, a critical vicious circle in neurodegenerative tauopathies? Oxidative Med Cell Longev 2015:151979","journal-title":"Oxidative Med Cell Longev"},{"key":"2328_CR5","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1074\/jbc.M409234200","volume":"280","author":"T Arai","year":"2005","unstructured":"Arai T, Guo J-P, Mcgeer PL (2005) Proteolysis of non-phosphorylated and phosphorylated tau by thrombin. J Biol Chem 280:5145\u20135153","journal-title":"J Biol Chem"},{"key":"2328_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s004010050002","volume":"100","author":"K Arima","year":"2000","unstructured":"Arima K, Mizutani T, Alim MA, Tonozuka-Uehara H, Izumiyama Y, Hirai S, U\u00e9da K (2000) NACP\/\u03b1-synuclein and tau constitute two distinctive subsets of filaments in the same neuronal inclusions in brains from a family of parkinsonism and dementia with Lewy bodies: double-immunolabeling fluorescence and electron microscopic studies. Acta Neuropathol 100:115\u2013121","journal-title":"Acta Neuropathol"},{"key":"2328_CR7","doi-asserted-by":"crossref","unstructured":"Avila J, Lucas JJ, Perez M, Hernandez F (2004) Role of tau protein in both physiological and pathological conditions. Physiol Rev","DOI":"10.1152\/physrev.00024.2003"},{"key":"2328_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1517\/14728222.2016.1131269","volume":"20","author":"J Avila","year":"2016","unstructured":"Avila J, Pallas N, Bol\u00f3s M, Sayas CL, Hernandez F (2016) Intracellular and extracellular microtubule associated protein tau as a therapeutic target in Alzheimer disease and other tauopathies. Expert Opin Ther Targets 20:653\u2013661","journal-title":"Expert Opin Ther Targets"},{"key":"2328_CR9","doi-asserted-by":"publisher","first-page":"e26609","DOI":"10.1371\/journal.pone.0026609","volume":"6","author":"N Badiola","year":"2011","unstructured":"Badiola N, De Oliveira RM, Herrera F, Guardia-Laguarta C, Goncalves SA, Pera M, Suarez-Calvet M, Clarimon J, Outeiro TF, Lleo A (2011) Tau enhances \u03b1-synuclein aggregation and toxicity in cellular models of synucleinopathy. PLoS ONE 6:e26609","journal-title":"PLoS ONE"},{"key":"2328_CR10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore C, Lee VM-Y, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders. Nat Rev Neurosci 8:663","journal-title":"Nat Rev Neurosci"},{"key":"2328_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3233\/JAD-160542","volume":"55","author":"WA Banks","year":"2016","unstructured":"Banks WA, Kovac A, Majerova P, Bullock KM, Shi M, Zhang J (2016) Tau proteins cross the blood-brain barrier. J Alzheimer\u2019s Disease 55:411\u2013419","journal-title":"J Alzheimer\u2019s Disease"},{"key":"2328_CR12","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3390\/antiox11081421","volume":"11","author":"F Bartolome","year":"2022","unstructured":"Bartolome F, Carro E, Alquezar C (2022) Oxidative stress in tauopathies: From cause to therapy. Antioxidants 11:1421","journal-title":"Antioxidants"},{"key":"2328_CR13","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/s41380-023-02113-z","volume":"28","author":"N Basheer","year":"2023","unstructured":"Basheer N, Smolek T, Hassan I, Liu F, Iqbal K, Zilka N, Novak P (2023) Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer\u2019s disease? From preclinical studies to the clinical trials. Mol Psychiatry 28:2197\u20132214","journal-title":"Mol Psychiatry"},{"key":"2328_CR14","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.ijbiomac.2018.08.175","volume":"120","author":"N Bijari","year":"2018","unstructured":"Bijari N, Balalaie S, Akbari V, Golmohammadi F, Moradi S, Adibi H, Khodarahmi R (2018) Effective suppression of the modified PHF6 peptide\/1N4R Tau amyloid aggregation by intact curcumin, not its degradation products: Another evidence for the pigment as preventive\/therapeutic functional food. Int J Biol Macromol 120:1009\u20131022","journal-title":"Int J Biol Macromol"},{"key":"2328_CR15","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1001\/archneurol.2012.90","volume":"69","author":"K Blennow","year":"2012","unstructured":"Blennow K, Zetterberg H, Rinne JO, Salloway S, Wei J, Black R, Grundman M, Liu E, Investigators A- (2012) Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease. Arch Neurol 69:1002\u20131010","journal-title":"Arch Neurol"},{"key":"2328_CR16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS (2014) Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71:505\u2013508","journal-title":"JAMA Neurol"},{"key":"2328_CR17","doi-asserted-by":"publisher","first-page":"653815","DOI":"10.3389\/fcell.2021.653815","volume":"9","author":"E Bok","year":"2021","unstructured":"Bok E, Leem E, Lee B-R, Lee JM, Yoo CJ, Lee EM, Kim J (2021) Role of the lipid membrane and membrane proteins in tau pathology. Front Cell Dev Biology 9:653815","journal-title":"Front Cell Dev Biology"},{"key":"2328_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-014-1373-0","volume":"129","author":"S Boluda","year":"2015","unstructured":"Boluda S, Iba M, Zhang B, Raible KM, Lee VM, Trojanowski JQ (2015) Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer\u2019s disease or corticobasal degeneration brains. Acta Neuropathol 129:221\u2013237","journal-title":"Acta Neuropathol"},{"key":"2328_CR19","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00018-019-03349-1","volume":"77","author":"CA Brunello","year":"2020","unstructured":"Brunello CA, Merezhko M, Uronen R-L, Huttunen HJ (2020) Mechanisms of secretion and spreading of pathological tau protein. Cell Mol Life Sci 77:1721\u20131744","journal-title":"Cell Mol Life Sci"},{"key":"2328_CR20","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.neuropharm.2010.01.016","volume":"59","author":"B Bulic","year":"2010","unstructured":"Bulic B, Pickhardt M, Mandelkow E-M, Mandelkow E (2010) Tau protein and tau aggregation inhibitors. Neuropharmacology 59:276\u2013289","journal-title":"Neuropharmacology"},{"key":"2328_CR21","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1021\/cn500148z","volume":"5","author":"MDC C\u00e1rdenas-Aguayo","year":"2014","unstructured":"C\u00e1rdenas-Aguayo MDC, G\u00f3Mez-Virgilio L, Derosa S, Meraz-R\u00edos MA (2014) The role of tau oligomers in the onset of Alzheimer\u2019s disease neuropathology. ACS Chem Neurosci 5:1178\u20131191","journal-title":"ACS Chem Neurosci"},{"key":"2328_CR22","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1523\/JNEUROSCI.3192-13.2014","volume":"34","author":"DL Castillo-Carranza","year":"2014","unstructured":"Castillo-Carranza DL, Sengupta U, Guerrero-Mu\u00f1oz MJ, Lasagna-Reeves CA, Gerson JE, Singh G, Estes DM, Barrett AD, Dineley KT, Jackson GR (2014) Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles. J Neurosci 34:4260\u20134272","journal-title":"J Neurosci"},{"key":"2328_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fnagi.2014.00232","volume":"6","author":"JF Castro-Alvarez","year":"2014","unstructured":"Castro-Alvarez JF, Uribe-Arias SA, Mej\u00eda-Raigosa D, Cardona-G\u00f3mez GP (2014) Cyclin-dependent kinase 5, a node protein in diminished tauopathy: a systems biology approach. Front Aging Neurosci 6:232","journal-title":"Front Aging Neurosci"},{"key":"2328_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/tra.12537","volume":"19","author":"AR Chaudhary","year":"2018","unstructured":"Chaudhary AR, Berger F, Berger CL, Hendricks AG (2018) Tau directs intracellular trafficking by regulating the forces exerted by kinesin and dynein teams. Traffic 19:111\u2013121","journal-title":"Traffic"},{"key":"2328_CR25","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1021\/acsnano.7b07625","volume":"12","author":"Q Chen","year":"2018","unstructured":"Chen Q, Du Y, Zhang K, Liang Z, Li J, Yu H, Ren R, Feng J, Jin Z, Li F (2018) Tau-targeted multifunctional nanocomposite for combinational therapy of Alzheimer\u2019s disease. ACS Nano 12:1321\u20131338","journal-title":"ACS Nano"},{"key":"2328_CR26","doi-asserted-by":"publisher","first-page":"320523","DOI":"10.3389\/fnins.2018.00163","volume":"12","author":"Y Cheng","year":"2018","unstructured":"Cheng Y, Bai F (2018) The association of tau with mitochondrial dysfunction in Alzheimer\u2019s disease. Front NeuroSci 12:320523","journal-title":"Front NeuroSci"},{"key":"2328_CR27","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.bpj.2009.04.047","volume":"97","author":"M Choi","year":"2009","unstructured":"Choi M, Raviv U, Miller H, Gaylord M, Kiris E, Ventimiglia D, Needleman D, Kim M-W, Wilson L, Feinstein S (2009) Human microtubule-associated-protein tau regulates the number of protofilaments in microtubules: a synchrotron x-ray scattering study. Biophys J 97:519\u2013527","journal-title":"Biophys J"},{"key":"2328_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nature13800","volume":"515","author":"SH Choi","year":"2014","unstructured":"Choi SH, Kim YH, Hebisch M, Sliwinski C, Lee S, D\u2019avanzo C, Chen H, Hooli B, Asselin C, Muffat J (2014) A three-dimensional human neural cell culture model of Alzheimer\u2019s disease. Nature 515:274\u2013278","journal-title":"Nature"},{"key":"2328_CR29","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1016\/j.bbadis.2018.07.011","volume":"1864","author":"D De Cieri","year":"2018","unstructured":"Cieri D, Vicario M, Vallese F, D\u2019orsi B, Berto P, Grinzato A, Catoni C, De Stefani D, Rizzuto R, Brini M (2018) Tau localises within mitochondrial sub-compartments and its caspase cleavage affects ER-mitochondria interactions and cellular Ca2+\u2009handling. Biochim Biophys Acta (BBA) Mol Basis Dis 1864:3247\u20133256","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"key":"2328_CR30","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909","journal-title":"Nat Cell Biol"},{"key":"2328_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00401-013-1231-5","volume":"127","author":"F Clavaguera","year":"2014","unstructured":"Clavaguera F, Hench J, Lavenir I, Schweighauser G, Frank S, Goedert M, Tolnay M (2014) Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice. Acta Neuropathol 127:299\u2013301","journal-title":"Acta Neuropathol"},{"key":"2328_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/ncomms1255","volume":"2","author":"TJ Cohen","year":"2011","unstructured":"Cohen TJ, Guo JL, Hurtado DE, Kwong LK, Mills IP, Trojanowski JQ, Lee VM (2011) The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat Commun 2:252","journal-title":"Nat Commun"},{"key":"2328_CR32","doi-asserted-by":"publisher","first-page":"e0158470","DOI":"10.1371\/journal.pone.0158470","volume":"11","author":"TJ Cohen","year":"2016","unstructured":"Cohen TJ, Constance BH, Hwang AW, James M, Yuan C-X (2016) Intrinsic tau acetylation is coupled to auto-proteolytic tau fragmentation. PLoS ONE 11:e0158470","journal-title":"PLoS ONE"},{"key":"2328_CR34","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1093\/brain\/awu213","volume":"137","author":"L Collin","year":"2014","unstructured":"Collin L, Bohrmann B, G\u00f6pfert U, Oroszlan-Szovik K, Ozmen L, Gr\u00fcninger F (2014) Neuronal uptake of tau\/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer\u2018s disease. Brain 137:2834\u20132846","journal-title":"Brain"},{"key":"2328_CR36","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon EE, Sigurdsson EM (2018) Tau-targeting therapies for Alzheimer disease. Nat Reviews Neurol 14:399\u2013415","journal-title":"Nat Reviews Neurol"},{"key":"2328_CR37","doi-asserted-by":"publisher","first-page":"609","DOI":"10.4161\/auto.19048","volume":"8","author":"EE Congdon","year":"2012","unstructured":"Congdon EE, Wu JW, Myeku N, Figueroa YH, Herman M, Marinec PS, Gestwicki JE, Dickey CA, Yu WH, Duff KE (2012) Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo. Autophagy 8:609\u2013622","journal-title":"Autophagy"},{"key":"2328_CR35","doi-asserted-by":"crossref","unstructured":"Congdon EE, Jiang Y, Sigurdsson EM (2022) Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra-and extracellularly. Seminars in cell & developmental biology, Elsevier, 125\u2013137","DOI":"10.1016\/j.semcdb.2021.12.002"},{"key":"2328_CR38","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fneur.2013.00114","volume":"4","author":"CM Cowan","year":"2013","unstructured":"Cowan CM, Mudher A (2013) Are tau aggregates toxic or protective in tauopathies? Front Neurol 4:114","journal-title":"Front Neurol"},{"key":"2328_CR39","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1042\/BST20120135","volume":"40","author":"CM Cowan","year":"2012","unstructured":"Cowan CM, Quraishe S, Mudher A (2012) What is the pathological significance of tau oligomers? Biochem Soc Trans 40:693\u2013697","journal-title":"Biochem Soc Trans"},{"key":"2328_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","volume":"38","author":"J Cummings","year":"2024","unstructured":"Cummings J, Osse AML, Cammann D, Powell J, Chen J (2024) Anti-amyloid monoclonal antibodies for the treatment of Alzheimer\u2019s disease. BioDrugs 38:5\u201322","journal-title":"BioDrugs"},{"key":"2328_CR41","doi-asserted-by":"publisher","first-page":"103392","DOI":"10.1016\/j.mcn.2019.103392","volume":"100","author":"C Cusulin","year":"2019","unstructured":"Cusulin C, Wells I, Badillo S, Duran-Pacheco GC, Baumann K, Patsch C (2019) Gamma secretase modulators and BACE inhibitors reduce A\u03b2 production without altering gene expression in Alzheimer\u2019s disease iPSC-derived neurons and mice. Mol Cell Neurosci 100:103392","journal-title":"Mol Cell Neurosci"},{"key":"2328_CR42","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00702-014-1315-y","volume":"122","author":"C-L Dai","year":"2015","unstructured":"Dai C-L, Chen X, Kazim SF, Liu F, Gong C-X, Grundke-Iqbal I, Iqbal K (2015) Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies. J Neural Transm 122:607\u2013617","journal-title":"J Neural Transm"},{"key":"2328_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-016-0227-5","volume":"9","author":"C-L Dai","year":"2017","unstructured":"Dai C-L, Tung YC, Liu F, Gong C-X, Iqbal K (2017) Tau passive immunization inhibits not only tau but also A\u03b2 pathology. Alzheimers Res Ther 9:1\u201316","journal-title":"Alzheimers Res Ther"},{"key":"2328_CR44","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1111\/j.1460-9568.2012.08084.x","volume":"35","author":"V Das","year":"2012","unstructured":"Das V, Miller JH (2012) Microtubule stabilization by peloruside A and paclitaxel rescues degenerating neurons from okadaic acid-induced tau phosphorylation. Eur J Neurosci 35:1705\u20131717","journal-title":"Eur J Neurosci"},{"key":"2328_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1046\/j.1471-4159.2002.01137.x","volume":"83","author":"DC David","year":"2002","unstructured":"David DC, Layfield R, Serpell L, Narain Y, Goedert M, Spillantini MG (2002) Proteasomal degradation of tau protein. J Neurochem 83:176\u2013185","journal-title":"J Neurochem"},{"key":"2328_CR46","doi-asserted-by":"publisher","first-page":"e0286523","DOI":"10.1371\/journal.pone.0286523","volume":"18","author":"EJ Davidowitz","year":"2023","unstructured":"Davidowitz EJ, Lopez P, Jimenez H, Adrien L, Davies P, Moe JG (2023) Small molecule inhibitor of tau self-association in a mouse model of tauopathy: A preventive study in P301L tau JNPL3 mice. PLoS ONE 18:e0286523","journal-title":"PLoS ONE"},{"key":"2328_CR47","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12967-024-04987-1","volume":"22","author":"N De Leiris","year":"2024","unstructured":"De Leiris N, Perret P, Lombardi C, G\u00f6zel B, Chierici S, Millet P, Debiossat M, Bacot S, Tournier BB, Chames P (2024) A single-domain antibody for the detection of pathological Tau protein in the early stages of oligomerization. J Translational Med 22:163","journal-title":"J Translational Med"},{"key":"2328_CR48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00401-006-0048-x","volume":"111","author":"R De Silva","year":"2006","unstructured":"De Silva R, Lashley T, Strand C, Shiarli A-M, Shi J, Tian J, Bailey KL, Davies P, Bigio EH, Arima K (2006) An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R-and 4R-specific tau monoclonal antibodies. Acta Neuropathol 111:329\u2013340","journal-title":"Acta Neuropathol"},{"key":"2328_CR49","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1172\/JCI29715","volume":"117","author":"CA Dickey","year":"2007","unstructured":"Dickey CA, Kamal A, Lundgren K, Klosak N, Bailey RM, Dunmore J, Ash P, Shoraka S, Zlatkovic J, Eckman CB (2007) The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J Clin Investig 117:648\u2013658","journal-title":"J Clin Investig"},{"key":"2328_CR50","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1126\/science.1152993","volume":"319","author":"R Dixit","year":"2008","unstructured":"Dixit R, Ross JL, Goldman YE, Holzbaur EL (2008) Differential regulation of dynein and kinesin motor proteins by tau. Science 319:1086\u20131089","journal-title":"Science"},{"key":"2328_CR51","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1073\/pnas.242720499","volume":"100","author":"F Dou","year":"2003","unstructured":"Dou F, Netzer WJ, Tanemura K, Li F, Hartl FU, Takashima A, Gouras GK, Greengard P, Xu H (2003) Chaperones increase association of tau protein with microtubules. Proc Natl Acad Sci 100:721\u2013726","journal-title":"Proc Natl Acad Sci"},{"key":"2328_CR52","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.3390\/polym15092196","volume":"15","author":"L Duan","year":"2023","unstructured":"Duan L, Li X, Ji R, Hao Z, Kong M, Wen X, Guan F, Ma S (2023) Nanoparticle-based drug delivery systems: an inspiring therapeutic strategy for neurodegenerative diseases. Polymers 15:2196","journal-title":"Polymers"},{"key":"2328_CR53","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.neuron.2012.06.026","volume":"75","author":"B Duboff","year":"2012","unstructured":"Duboff B, G\u00f6tz J, Feany MB (2012) Tau promotes neurodegeneration via DRP1 mislocalization in vivo. Neuron 75:618\u2013632","journal-title":"Neuron"},{"key":"2328_CR55","doi-asserted-by":"publisher","first-page":"e100760","DOI":"10.1371\/journal.pone.0100760","volume":"9","author":"S Dujardin","year":"2014","unstructured":"Dujardin S, Begard S, Caillierez R, Lachaud C, Delattre L, Carrier S, Loyens A, Galas M-C, Bousset L, Melki R (2014) Ectosomes: a new mechanism for non-exosomal secretion of tau protein. PLoS ONE 9:e100760","journal-title":"PLoS ONE"},{"key":"2328_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-018-0637-7","volume":"6","author":"S Dujardin","year":"2018","unstructured":"Dujardin S, B\u00e9gard S, Caillierez R, Lachaud C, Carrier S, Lieger S, Gonzalez JA, Deramecourt V, D\u00e9glon N, Maurage C-A (2018) Different tau species lead to heterogeneous tau pathology propagation and misfolding. Acta Neuropathol Commun 6:1\u201312","journal-title":"Acta Neuropathol Commun"},{"key":"2328_CR56","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1096\/fj.08-120410","volume":"23","author":"T Duka","year":"2009","unstructured":"Duka T, Duka V, Joyce JN, Sidhu A (2009) \u03b1-Synuclein contributes to GSK-3\u03b2-catalyzed Tau phosphorylation in Parkinson\u2019s disease models. FASEB J 23:2820","journal-title":"FASEB J"},{"key":"2328_CR57","doi-asserted-by":"publisher","first-page":"40162","DOI":"10.1074\/jbc.M308243200","volume":"278","author":"A Ferrari","year":"2003","unstructured":"Ferrari A, Hoerndli F, Baechi T, Nitsch RM, G\u00f6Tz JR (2003) \u03b2-Amyloid induces paired helical filament-like tau filaments in tissue culture. J Biol Chem 278:40162\u201340168","journal-title":"J Biol Chem"},{"key":"2328_CR58","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3390\/biom12111676","volume":"12","author":"Z Fi\u0161ar","year":"2022","unstructured":"Fi\u0161ar Z (2022) Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer\u2019s Disease and Identifying Promising Drug Targets. Biomolecules 12:1676","journal-title":"Biomolecules"},{"key":"2328_CR59","doi-asserted-by":"crossref","unstructured":"Forman M, Palcza J, Tseng J, Leempoels J, Ramael S, Han D, Jhee S, Ereshefsky L, Tanen M, Laterza O (2012) P4-196: the novel BACE inhibitor MK\u20108931 dramatically lowers cerebrospinal fluid A\u03b2 peptides in healthy subjects following single\u2010and multiple\u2010dose administration. Alzheimer\u2019s Dement 8:P704\u2013P704","DOI":"10.1016\/j.jalz.2012.05.1900"},{"key":"2328_CR60","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrn2786","volume":"11","author":"B Frost","year":"2010","unstructured":"Frost B, Diamond MI (2010) Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci 11:155\u2013159","journal-title":"Nat Rev Neurosci"},{"key":"2328_CR61","doi-asserted-by":"publisher","first-page":"12845","DOI":"10.1074\/jbc.M808759200","volume":"284","author":"B Frost","year":"2009","unstructured":"Frost B, Jacks RL, Diamond MI (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284:12845\u201312852","journal-title":"J Biol Chem"},{"key":"2328_CR62","doi-asserted-by":"publisher","first-page":"175","DOI":"10.21037\/atm.2018.04.23","volume":"6","author":"Y-L Gao","year":"2018","unstructured":"Gao Y-L, Wang N, Sun F-R, Cao X-P, Zhang W, Yu J-T (2018) Tau in neurodegenerative disease. Ann Transl Med 6:175","journal-title":"Ann Transl Med"},{"key":"2328_CR63","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/j.1471-4159.2007.04613.x","volume":"102","author":"M Garcia-Alloza","year":"2007","unstructured":"Garcia-Alloza M, Borrelli L, Rozkalne A, Hyman B, Bacskai B (2007) Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102:1095\u20131104","journal-title":"J Neurochem"},{"key":"2328_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-4-13","volume":"4","author":"TF Gendron","year":"2009","unstructured":"Gendron TF, Petrucelli L (2009) The role of tau in neurodegeneration. Mol neurodegeneration 4:1\u201319","journal-title":"Mol neurodegeneration"},{"key":"2328_CR65","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1080\/10409238.2016.1226251","volume":"51","author":"JE Gerson","year":"2016","unstructured":"Gerson JE, Mudher A, Kayed R (2016) Potential mechanisms and implications for the formation of tau oligomeric strains. Crit Rev Biochem Mol Biol 51:482\u2013496","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"2328_CR66","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1082324","volume":"300","author":"BI Giasson","year":"2003","unstructured":"Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, Trojanowski JQ, Lee VM-Y (2003) Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300:636\u2013640","journal-title":"Science"},{"key":"2328_CR67","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.1021\/acs.jmedchem.7b00632","volume":"60","author":"LC Gobbi","year":"2017","unstructured":"Gobbi LC, Knust H, K\u00f6Rner M, Honer M, Czech C, Belli S, Muri D, Edelmann MR, Hartung T, Erbsmehl I (2017) Identification of three novel radiotracers for imaging aggregated tau in Alzheimer\u2019s disease with positron emission tomography. J Med Chem 60:7350\u20137370","journal-title":"J Med Chem"},{"key":"2328_CR68","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.1132814","volume":"314","author":"M Goedert","year":"2006","unstructured":"Goedert M, Spillantini MG (2006) A century of Alzheimer\u2019s disease. Science 314:777\u2013781","journal-title":"Science"},{"key":"2328_CR69","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.3233\/JAD-2004-6S605","volume":"6","author":"I Gozes","year":"2004","unstructured":"Gozes I, Divinski I (2004) The femtomolar-acting NAP interacts with microtubules: novel aspects of astrocyte protection. J Alzheimers Dis 6:S37\u2013S41","journal-title":"J Alzheimers Dis"},{"key":"2328_CR70","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1007\/s12035-020-02084-0","volume":"57","author":"S Guha","year":"2020","unstructured":"Guha S, Johnson GV, Nehrke K (2020) The crosstalk between pathological tau phosphorylation and mitochondrial dysfunction as a key to understanding and treating Alzheimer\u2019s disease. Mol Neurobiol 57:5103\u20135120","journal-title":"Mol Neurobiol"},{"key":"2328_CR71","doi-asserted-by":"publisher","first-page":"15317","DOI":"10.1074\/jbc.M110.209296","volume":"286","author":"JL Guo","year":"2011","unstructured":"Guo JL, Lee VM-Y (2011) Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem 286:15317\u201315331","journal-title":"J Biol Chem"},{"key":"2328_CR72","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","volume":"133","author":"T Guo","year":"2017","unstructured":"Guo T, Noble W, Hanger DP (2017) Roles of tau protein in health and disease. Acta Neuropathol 133:665\u2013704","journal-title":"Acta Neuropathol"},{"key":"2328_CR73","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1460-9568.2008.06084.x","volume":"27","author":"T Hamano","year":"2008","unstructured":"Hamano T, Gendron TF, Causevic E, Yen SH, Lin WL, Isidoro C, Deture M, Ko LW (2008) Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild\u2010type tau expression. Eur J Neurosci 27:1119\u20131130","journal-title":"Eur J Neurosci"},{"key":"2328_CR74","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","volume":"15","author":"DP Hanger","year":"2009","unstructured":"Hanger DP, Anderton BH, Noble W (2009) Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med 15:112\u2013119","journal-title":"Trends Mol Med"},{"key":"2328_CR75","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3390\/ijms20081959","volume":"20","author":"MM Haque","year":"2019","unstructured":"Haque MM, Murale DP, Kim YK, Lee J-S (2019) Crosstalk between oxidative stress and tauopathy. Int J Mol Sci 20:1959","journal-title":"Int J Mol Sci"},{"key":"2328_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-015-0204-4","volume":"3","author":"K Hochgr\u00e4fe","year":"2015","unstructured":"Hochgr\u00e4fe K, Sydow A, Matenia D, Cadinu D, K\u00f6nen S, Petrova O, Pickhardt M, Goll P, Morellini F, Mandelkow E (2015) Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau. Acta Neuropathol Commun 3:1\u201322","journal-title":"Acta Neuropathol Commun"},{"key":"2328_CR77","doi-asserted-by":"publisher","first-page":"19855","DOI":"10.1074\/jbc.R114.549295","volume":"289","author":"BB Holmes","year":"2014","unstructured":"Holmes BB, Diamond MI (2014) Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target. J Biol Chem 289:19855\u201319861","journal-title":"J Biol Chem"},{"key":"2328_CR78","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, Pitstick R, Carlson GA, Lanier LM, Yuan L-L (2010a) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68:1067\u20131081","journal-title":"Neuron"},{"key":"2328_CR79","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, Pitstick R, Carlson GA, Lanier LM, Yuan L-L (2010b) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68:1067\u20131081","journal-title":"Neuron"},{"key":"2328_CR80","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1002\/1873-3468.13218","volume":"592","author":"T Ikura","year":"2018","unstructured":"Ikura T, Tochio N, Kawasaki R, Matsuzaki M, Narita A, Kikumoto M, Utsunomiya-Tate N, Tate SI, Ito N (2018) The trans isomer of Tau peptide is prone to aggregate, and the WW domain of Pin1 drastically decreases its aggregation. FEBS Lett 592:3082\u20133091","journal-title":"FEBS Lett"},{"key":"2328_CR81","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","volume":"12","author":"K Iqbal","year":"2016","unstructured":"Iqbal K, Liu F, Gong C-X (2016) Tau and neurodegenerative disease: the story so far. Nat reviews Neurol 12:15\u201327","journal-title":"Nat reviews Neurol"},{"key":"2328_CR82","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/jnen\/62.4.389","volume":"62","author":"T Ishizawa","year":"2003","unstructured":"Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW (2003) Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. J Neuropathology Experimental Neurol 62:389\u2013397","journal-title":"J Neuropathology Experimental Neurol"},{"key":"2328_CR83","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, Schwartz S, Albasset S, Mcmanus RM, Tejera D (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575:669\u2013673","journal-title":"Nature"},{"key":"2328_CR84","doi-asserted-by":"publisher","first-page":"114979","DOI":"10.1016\/j.bcp.2022.114979","volume":"198","author":"M Islam","year":"2022","unstructured":"Islam M, Shen F, Regmi D, Du D (2022) Therapeutic strategies for tauopathies and drug repurposing as a potential approach. Biochem Pharmacol 198:114979","journal-title":"Biochem Pharmacol"},{"key":"2328_CR85","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner LM, G\u00f6tz J (2011) Amyloid-\u03b2 and tau\u2014a toxic pas de deux in Alzheimer\u2019s disease. Nat Rev Neurosci 12:67\u201372","journal-title":"Nat Rev Neurosci"},{"key":"2328_CR86","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, Van Eersel J, W\u00f6lfing H, Chieng BC, Christie MJ, Napier IA (2010) Dendritic function of tau mediates amyloid-\u03b2 toxicity in Alzheimer\u2019s disease mouse models. Cell 142:387\u2013397","journal-title":"Cell"},{"key":"2328_CR87","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.redox.2018.07.010","volume":"18","author":"C Jara","year":"2018","unstructured":"Jara C, Ar\u00e1nguiz A, Cerpa W, Tapia-Rojas C, Quintanilla RA (2018) Genetic ablation of tau improves mitochondrial function and cognitive abilities in the hippocampus. Redox Biol 18:279\u2013294","journal-title":"Redox Biol"},{"key":"2328_CR88","doi-asserted-by":"publisher","first-page":"25481","DOI":"10.1074\/jbc.274.36.25481","volume":"274","author":"PH Jensen","year":"1999","unstructured":"Jensen PH, Hager H, Nielsen MS, H\u00f8jrup P, Gliemann J, Jakes R (1999) \u03b1-Synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. J Biol Chem 274:25481\u201325489","journal-title":"J Biol Chem"},{"key":"2328_CR89","doi-asserted-by":"crossref","unstructured":"Kammula SV, Tripathi S, Wang N, Dawson VL, Dawson TM, Mao X (2023) Unraveling the tau puzzle: a review of mechanistic targets and therapeutic interventions to prevent tau pathology in Alzheimer\u2019s disease","DOI":"10.20517\/and.2023.20"},{"key":"2328_CR90","doi-asserted-by":"publisher","first-page":"24314","DOI":"10.18632\/oncotarget.15149","volume":"8","author":"Q Kang","year":"2017","unstructured":"Kang Q, Xiang Y, Li D, Liang J, Zhang X, Zhou F, Qiao M, Nie Y, He Y, Cheng J (2017) MiR-124-3p attenuates hyperphosphorylation of Tau protein-induced apoptosis via caveolin-1-PI3K\/Akt\/GSK3\u03b2 pathway in N2a\/APP695swe cells. Oncotarget 8:24314","journal-title":"Oncotarget"},{"key":"2328_CR91","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.nbd.2014.08.004","volume":"71","author":"T-T Kao","year":"2014","unstructured":"Kao T-T, Chu C-Y, Lee G-H, Hsiao T-H, Cheng N-W, Chang N-S, Chen B-H, Fu T-F (2014) Folate deficiency-induced oxidative stress contributes to neuropathy in young and aged zebrafish\u2014implication in neural tube defects and Alzheimer\u2019s diseases. Neurobiol Dis 71:234\u2013244","journal-title":"Neurobiol Dis"},{"key":"2328_CR92","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch CM, Goate AM (2015) Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 77:43\u201351","journal-title":"Biol Psychiatry"},{"key":"2328_CR93","doi-asserted-by":"publisher","first-page":"8147080","DOI":"10.1155\/2020\/8147080","volume":"2020","author":"LM Kassem","year":"2020","unstructured":"Kassem LM, Ibrahim NA, Farhana SA (2020) Nanoparticle therapy is a promising approach in the management and prevention of many diseases: does it help in curing Alzheimer disease? J Nanotechnol 2020:8147080","journal-title":"J Nanotechnol"},{"key":"2328_CR94","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.neuron.2016.09.055","volume":"92","author":"SK Kaufman","year":"2016","unstructured":"Kaufman SK, Sanders DW, Thomas TL, Ruchinskas AJ, Vaquer-Alicea J, Sharma AM, Miller TM, Diamond MI (2016) Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo. Neuron 92:796\u2013812","journal-title":"Neuron"},{"key":"2328_CR95","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1111\/j.1742-4658.2011.08389.x","volume":"278","author":"F Kawakami","year":"2011","unstructured":"Kawakami F, Suzuki M, Shimada N, Kagiya G, Ohta E, Tamura K, Maruyama H, Ichikawa T (2011) Stimulatory effect of \u03b1-synuclein on the tau\u2010phosphorylation by GSK\u20103\u03b2. FEBS J 278:4895\u20134904","journal-title":"FEBS J"},{"key":"2328_CR96","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1046\/j.1471-4159.1997.69052026.x","volume":"69","author":"A Kenessey","year":"1997","unstructured":"Kenessey A, Nacharaju P, Ko LW, Yen SH (1997) Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration. J Neurochem 69:2026\u20132038","journal-title":"J Neurochem"},{"key":"2328_CR97","doi-asserted-by":"publisher","first-page":"101924","DOI":"10.1016\/j.arr.2023.101924","volume":"87","author":"S Khan","year":"2023","unstructured":"Khan S, Hassan MI, Shahid M, Islam A (2023) Nature\u2019s toolbox against tau aggregation: An updated review of current research. Ageing Res Rev 87:101924","journal-title":"Ageing Res Rev"},{"key":"2328_CR98","doi-asserted-by":"crossref","unstructured":"Khanna MR, Kovalevich J, Lee VM-Y, Trojanowski JQ, Brunden KR (2016) Therapeutic strategies for the treatment of tauopathies: Hopes and challenges, vol 12. Alzheimer\u2019s & Dementia, pp 1051\u20131065","DOI":"10.1016\/j.jalz.2016.06.006"},{"key":"2328_CR99","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.nbd.2015.12.006","volume":"87","author":"Y Kim","year":"2016","unstructured":"Kim Y, Choi H, Lee W, Park H, Kam T-I, Hong S-H, Nah J, Jung S, Shin B, Lee H (2016) Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model. Neurobiol Dis 87:19\u201328","journal-title":"Neurobiol Dis"},{"key":"2328_CR100","first-page":"731526","volume":"2012","author":"M Kolarova","year":"2012","unstructured":"Kolarova M, Garc\u00eda-Sierra F, Bartos A, Ricny J, Ripova D (2012) Structure and pathology of tau protein in Alzheimer disease. Int J Alzheimer\u2019s disease 2012:731526","journal-title":"Int J Alzheimer\u2019s disease"},{"key":"2328_CR101","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature14658","volume":"523","author":"A Kondo","year":"2015","unstructured":"Kondo A, Shahpasand K, Mannix R, Qiu J, Moncaster J, Chen C-H, Yao Y, Lin Y-M, Driver JA, Sun Y (2015) Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy. Nature 523:431\u2013436","journal-title":"Nature"},{"key":"2328_CR102","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.expneurol.2004.01.007","volume":"187","author":"PT Kotzbauer","year":"2004","unstructured":"Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, Trojanowski JQ, Lee VM-Y (2004) Fibrillization of \u03b1-synuclein and tau in familial Parkinson\u2019s disease caused by the A53T \u03b1-synuclein mutation. Exp Neurol 187:279\u2013288","journal-title":"Exp Neurol"},{"key":"2328_CR103","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/j.neurobiolaging.2011.11.009","volume":"33","author":"U Kr\u00fcger","year":"2012","unstructured":"Kr\u00fcger U, Wang Y, Kumar S, Mandelkow E-M (2012) Autophagic degradation of tau in primary neurons and its enhancement by trehalose. Neurobiol Aging 33:2291\u20132305","journal-title":"Neurobiol Aging"},{"key":"2328_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12937-016-0186-5","volume":"15","author":"EB Kurutas","year":"2015","unstructured":"Kurutas EB (2015) The importance of antioxidants which play the role in cellular response against oxidative\/nitrosative stress: current state. Nutr J 15:1\u201322","journal-title":"Nutr J"},{"key":"2328_CR105","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1326-6-39","volume":"6","author":"CA Lasagna-Reeves","year":"2011","unstructured":"Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Clos AL, Jackson GR, Kayed R (2011a) Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol neurodegeneration 6:39","journal-title":"Mol neurodegeneration"},{"key":"2328_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-6-39","volume":"6","author":"CA Lasagna-Reeves","year":"2011","unstructured":"Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Clos AL, Jackson GR, Kayed R (2011b) Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol neurodegeneration 6:1\u201314","journal-title":"Mol neurodegeneration"},{"key":"2328_CR107","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1096\/fj.11-199851","volume":"26","author":"CA Lasagna-Reeves","year":"2012","unstructured":"Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Sarmiento J, Troncoso J, Jackson GR, Kayed R (2012) Identification of oligomers at early stages of tau aggregation in Alzheimer\u2019s disease. FASEB J 26:1946\u20131959","journal-title":"FASEB J"},{"key":"2328_CR108","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","volume":"24","author":"VM Lee","year":"2001","unstructured":"Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121\u20131159","journal-title":"Annu Rev Neurosci"},{"key":"2328_CR109","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","volume":"24","author":"A Leuzy","year":"2019","unstructured":"Leuzy A, Chiotis K, Lemoine L, Gillberg P-G, Almkvist O, Rodriguez-Vieitez E, Nordberg A (2019) Tau PET imaging in neurodegenerative tauopathies\u2014still a challenge. Mol Psychiatry 24:1112\u20131134","journal-title":"Mol Psychiatry"},{"key":"2328_CR111","doi-asserted-by":"publisher","first-page":"24756","DOI":"10.1038\/srep24756","volume":"6","author":"X-C Li","year":"2016","unstructured":"Li X-C, Hu Y, Wang Z-H, Luo Y, Zhang Y, Liu X-P, Feng Q, Wang Q, Ye K, Liu G-P (2016) Human wild-type full-length tau accumulation disrupts mitochondrial dynamics and the functions via increasing mitofusins. Sci Rep 6:24756","journal-title":"Sci Rep"},{"key":"2328_CR110","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10565-022-09761-x","volume":"39","author":"S Li","year":"2023","unstructured":"Li S, Lei Z, Sun T (2023) The role of microRNAs in neurodegenerative diseases: a review. Cell Biol Toxicol 39:53\u201383","journal-title":"Cell Biol Toxicol"},{"key":"2328_CR112","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3233\/JAD-190419","volume":"71","author":"T Liang","year":"2019","unstructured":"Liang T, Xue F, Hang W, Wen B, Zhang Q, Chen J, Liu X, Chen J (2019) Neuron-specific apolipoprotein E4 (1-272) fragment induces tau hyperphosphorylation and axonopathy via triggering endoplasmic reticulum stress. J Alzheimers Dis 71:597\u2013611","journal-title":"J Alzheimers Dis"},{"key":"2328_CR113","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/S0021-9258(18)45982-0","volume":"267","author":"JM Litersky","year":"1992","unstructured":"Litersky JM, Johnson G (1992) Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. J Biol Chem 267:1563\u20131568","journal-title":"J Biol Chem"},{"key":"2328_CR114","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","volume":"22","author":"F Liu","year":"2005","unstructured":"Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 22:1942\u20131950","journal-title":"Eur J Neurosci"},{"key":"2328_CR117","doi-asserted-by":"publisher","first-page":"352723","DOI":"10.1155\/2015\/352723","volume":"2015","author":"Z Liu","year":"2015","unstructured":"Liu Z, Li T, Li P, Wei N, Zhao Z, Liang H, Ji X, Chen W, Xue M, Wei J (2015) The ambiguous relationship of oxidative stress, tau hyperphosphorylation, and autophagy dysfunction in Alzheimer\u2019s disease. Oxidative Med Cell Longev 2015:352723","journal-title":"Oxidative Med Cell Longev"},{"key":"2328_CR115","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.bbrc.2016.08.037","volume":"478","author":"W Liu","year":"2016","unstructured":"Liu W, Zhao J, Lu G (2016) miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer\u2019s disease. Biochem Biophys Res Commun 478:852\u2013857","journal-title":"Biochem Biophys Res Commun"},{"key":"2328_CR116","doi-asserted-by":"publisher","first-page":"1022821","DOI":"10.3389\/fnagi.2022.1022821","volume":"14","author":"X Liu","year":"2022","unstructured":"Liu X, Ye M, Ma L (2022) The emerging role of autophagy and mitophagy in tauopathies: From pathogenesis to translational implications in Alzheimer\u2019s disease. Front Aging Neurosci 14:1022821","journal-title":"Front Aging Neurosci"},{"key":"2328_CR118","first-page":"2580","volume":"27","author":"S Lopes","year":"2017","unstructured":"Lopes S, Teplytska L, Vaz-Silva J, Dioli C, Trindade R, Morais M, Webhofer C, Maccarrone G, Almeida OF, Turck CW (2017) Tau deletion prevents stress-induced dendritic atrophy in prefrontal cortex: role of synaptic mitochondria. Cereb Cortex 27:2580\u20132591","journal-title":"Cereb Cortex"},{"key":"2328_CR119","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrn1847","volume":"7","author":"A Louvi","year":"2006","unstructured":"Louvi A, Artavanis-Tsakonas S (2006) Notch signalling in vertebrate neural development. Nat Rev Neurosci 7:93\u2013102","journal-title":"Nat Rev Neurosci"},{"key":"2328_CR120","doi-asserted-by":"publisher","first-page":"16586","DOI":"10.1073\/pnas.1417548111","volume":"111","author":"H-B Luo","year":"2014","unstructured":"Luo H-B, Xia Y-Y, Shu X-J, Liu Z-C, Feng Y, Liu X-H, Yu G, Yin G, Xiong Y-S, Zeng K (2014) SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination. Proc Natl Acad Sci 111:16586\u201316591","journal-title":"Proc Natl Acad Sci"},{"key":"2328_CR121","doi-asserted-by":"publisher","first-page":"101145","DOI":"10.1016\/j.mtbio.2024.101145","volume":"27","author":"R Ma","year":"2024","unstructured":"Ma R, Mu Q, Xi Y, Liu G, Liu C (2024) Nanotechnology for Tau pathology in Alzheimer\u2019s disease. Mater Today Bio 27:101145","journal-title":"Mater Today Bio"},{"key":"2328_CR122","doi-asserted-by":"publisher","first-page":"671458","DOI":"10.3389\/fmolb.2021.671458","volume":"8","author":"D Mah","year":"2021","unstructured":"Mah D, Zhao J, Liu X, Zhang F, Liu J, Wang L, Linhardt R, Wang C (2021) The sulfation code of tauopathies: heparan sulfate proteoglycans in the prion like spread of tau pathology. Front Mol Biosci 8:671458","journal-title":"Front Mol Biosci"},{"key":"2328_CR123","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1093\/hmg\/dds072","volume":"21","author":"M Manczak","year":"2012","unstructured":"Manczak M, Reddy PH (2012) Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer\u2019s disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum Mol Genet 21:2538\u20132547","journal-title":"Hum Mol Genet"},{"key":"2328_CR124","doi-asserted-by":"crossref","unstructured":"Mandelkow E-M, Mandelkow E (2012) Biochemistry and cell biology of tau protein in neurofibrillary degeneration, vol 2. Cold Spring Harbor perspectives in medicine, p a006247","DOI":"10.1101\/cshperspect.a006247"},{"key":"2328_CR125","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neuron.2005.05.010","volume":"46","author":"E Masliah","year":"2005","unstructured":"Masliah E, Rockenstein E, Adame A, Alford M, Crews L, Hashimoto M, Seubert P, Lee M, Goldstein J, Chilcote T (2005) Effects of \u03b1-synuclein immunization in a mouse model of Parkinson\u2019s disease. Neuron 46:857\u2013868","journal-title":"Neuron"},{"key":"2328_CR126","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nature02621","volume":"430","author":"MP Mattson","year":"2004","unstructured":"Mattson MP (2004) Pathways towards and away from Alzheimer\u2019s disease. Nature 430:631","journal-title":"Nature"},{"key":"2328_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-018-0574-5","volume":"6","author":"BF Maziuk","year":"2018","unstructured":"Maziuk BF, Apicco DJ, Cruz AL, Jiang L, Ash PE, Rocha D, Zhang EL, Yu C, Leszyk WH, Abisambra J, J. F (2018) RNA binding proteins co-localize with small tau inclusions in tauopathy. Acta Neuropathol Commun 6:1\u201314","journal-title":"Acta Neuropathol Commun"},{"key":"2328_CR128","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.brainres.2008.01.095","volume":"1207","author":"AC Mckee","year":"2008","unstructured":"Mckee AC, Carreras I, Hossain L, Ryu H, Klein WL, Oddo S, Laferla FM, Jenkins BG, Kowall NW, Dedeoglu A (2008) Ibuprofen reduces A\u03b2, hyperphosphorylated tau and memory deficits in Alzheimer mice. Brain Res 1207:225\u2013236","journal-title":"Brain Res"},{"key":"2328_CR129","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.3390\/ijms19041160","volume":"19","author":"M Medina","year":"2018","unstructured":"Medina M (2018) An overview on the clinical development of tau-based therapeutics. Int J Mol Sci 19:1160","journal-title":"Int J Mol Sci"},{"key":"2328_CR130","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.2174\/138161210793176581","volume":"16","author":"M Medina","year":"2010","unstructured":"Medina M, Avila J (2010) Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer\u2019s disease. Curr Pharm Design 16:2790\u20132798","journal-title":"Curr Pharm Design"},{"key":"2328_CR131","doi-asserted-by":"publisher","first-page":"518","DOI":"10.2174\/1389203724666230530143704","volume":"24","author":"M Mehrabi","year":"2023","unstructured":"Mehrabi M, Bijari N, Akbari V, Ranjbar S, Karima S, Sankian M, Ojaghi S, Khodarahmi R (2023) Effective Reduction of Tau Amyloid Aggregates in the Presence of Cyclophilin from Platanus orientalis Pollens; An Alternative Mechanism of Action of the Allergen. Curr Protein Pept Sci 24:518\u2013532","journal-title":"Curr Protein Pept Sci"},{"key":"2328_CR132","doi-asserted-by":"publisher","first-page":"e536","DOI":"10.1371\/journal.pone.0000536","volume":"2","author":"S Melov","year":"2007","unstructured":"Melov S, Adlard PA, Morten K, Johnson F, Golden TR, Hinerfeld D, Schilling B, Mavros C, Masters CL, Volitakis I (2007) Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS ONE 2:e536","journal-title":"PLoS ONE"},{"key":"2328_CR133","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0014-5793(95)00590-6","volume":"368","author":"M Mercken","year":"1995","unstructured":"Mercken M, Grynspan F, Nixon R (1995) Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF-tau. FEBS Lett 368:10\u201314","journal-title":"FEBS Lett"},{"key":"2328_CR134","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.neuron.2010.08.044","volume":"67","author":"S-W Min","year":"2010","unstructured":"Min S-W, Cho S-H, Zhou Y, Schroeder S, Haroutunian V, Seeley WW, Huang EJ, Shen Y, Masliah E, Mukherjee C (2010) Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67:953\u2013966","journal-title":"Neuron"},{"key":"2328_CR135","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3390\/biomedicines11061752","volume":"11","author":"SN Mir Najib Ullah","year":"2023","unstructured":"Mir Najib Ullah SN, Afzal O, Altamimi ASA, Ather H, Sultana S, Almalki WH, Bharti P, Sahoo A, Dwivedi K, Khan G (2023) Nanomedicine in the management of Alzheimer\u2019s disease: State-of-the-art. Biomedicines 11:1752","journal-title":"Biomedicines"},{"key":"2328_CR136","doi-asserted-by":"publisher","first-page":"844211","DOI":"10.3389\/fncel.2022.844211","volume":"16","author":"E Moretto","year":"2022","unstructured":"Moretto E, Stuart S, Surana S, Vargas JNS, Schiavo G (2022) The role of extracellular matrix components in the spreading of pathological protein aggregates. Front Cell Neurosci 16:844211","journal-title":"Front Cell Neurosci"},{"key":"2328_CR137","doi-asserted-by":"publisher","first-page":"6960","DOI":"10.1021\/bi400866w","volume":"52","author":"OA Morozova","year":"2013","unstructured":"Morozova OA, March ZM, Robinson AS, Colby DW (2013) Conformational features of tau fibrils from Alzheimer\u2019s disease brain are faithfully propagated by unmodified recombinant protein. Biochemistry 52:6960\u20136967","journal-title":"Biochemistry"},{"key":"2328_CR139","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","volume":"70","author":"M Morris","year":"2011","unstructured":"Morris M, Maeda S, Vossel K, Mucke L (2011) The many faces of tau. Neuron 70:410\u2013426","journal-title":"Neuron"},{"key":"2328_CR138","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/nn.4067","volume":"18","author":"M Morris","year":"2015","unstructured":"Morris M, Knudsen GM, Maeda S, Trinidad JC, Ioanoviciu A, Burlingame AL, Mucke L (2015) Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice. Nat Neurosci 18:1183\u20131189","journal-title":"Nat Neurosci"},{"key":"2328_CR140","doi-asserted-by":"publisher","first-page":"610037","DOI":"10.3389\/fnmol.2020.610037","volume":"13","author":"SL Morris","year":"2021","unstructured":"Morris SL, Tsai M-Y, Aloe S, Bechberger K, K\u00f6nig S, Morfini G, Brady ST (2021) Defined tau phosphospecies differentially inhibit fast axonal transport through activation of two independent signaling pathways. Front Mol Neurosci 13:610037","journal-title":"Front Mol Neurosci"},{"key":"2328_CR141","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.cell.2012.02.016","volume":"149","author":"K Nakamura","year":"2012","unstructured":"Nakamura K, Greenwood A, Binder L, Bigio EH, Denial S, Nicholson L, Zhou XZ, Lu KP (2012) Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer\u2019s disease. Cell 149:232\u2013244","journal-title":"Cell"},{"key":"2328_CR142","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3389\/fnins.2020.00494","volume":"14","author":"S Naqvi","year":"2020","unstructured":"Naqvi S, Panghal A, Flora S (2020) Nanotechnology: a promising approach for delivery of neuroprotective drugs. Front NeuroSci 14:494","journal-title":"Front NeuroSci"},{"key":"2328_CR143","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00401-014-1371-2","volume":"129","author":"RM Nisbet","year":"2015","unstructured":"Nisbet RM, Polanco J-C, Ittner LM, G\u00f6tz J (2015) Tau aggregation and its interplay with amyloid-\u03b2. Acta Neuropathol 129:207\u2013220","journal-title":"Acta Neuropathol"},{"key":"2328_CR144","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fneur.2013.00083","volume":"4","author":"W Noble","year":"2013","unstructured":"Noble W, Hanger DP, Miller CC, Lovestone S (2013) The importance of tau phosphorylation for neurodegenerative diseases. Front Neurol 4:83","journal-title":"Front Neurol"},{"key":"2328_CR145","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O\u2019brien","year":"2011","unstructured":"O\u2019brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci 34:185\u2013204","journal-title":"Annu Rev Neurosci"},{"key":"2328_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-5-45","volume":"5","author":"JC O\u2019leary","year":"2010","unstructured":"O\u2019leary JC, Li Q, Marinec P, Blair LJ, Congdon EE, Johnson AG, Jinwal UK, Koren J, Jones JR, Kraft C (2010) Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden. Mol neurodegeneration 5:1\u201311","journal-title":"Mol neurodegeneration"},{"key":"2328_CR147","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/antiox12020517","volume":"12","author":"EO Olufunmilayo","year":"2023","unstructured":"Olufunmilayo EO, Gerke-Duncan MB, Holsinger RD (2023) Oxidative stress and antioxidants in neurodegenerative disorders. Antioxidants 12:517","journal-title":"Antioxidants"},{"key":"2328_CR148","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","volume":"32","author":"WM Pardridge","year":"2012","unstructured":"Pardridge WM (2012) Drug transport across the blood\u2013brain barrier. J Cereb blood flow metabolism 32:1959\u20131972","journal-title":"J Cereb blood flow metabolism"},{"key":"2328_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0312-x","volume":"14","author":"TK Patel","year":"2019","unstructured":"Patel TK, Habimana-Griffin L, Gao X, Xu B, Achilefu S, Alitalo K, Mckee CA, Sheehan PW, Musiek ES, Xiong C (2019) Dural lymphatics regulate clearance of extracellular tau from the CNS. Mol neurodegeneration 14:1\u20139","journal-title":"Mol neurodegeneration"},{"key":"2328_CR150","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.molmed.2015.03.003","volume":"21","author":"JT Pedersen","year":"2015","unstructured":"Pedersen JT, Sigurdsson EM (2015) Tau immunotherapy for Alzheimer\u2019s disease. Trends Mol Med 21:394\u2013402","journal-title":"Trends Mol Med"},{"key":"2328_CR151","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fnins.2018.00441","volume":"12","author":"MJ P\u00e9rez","year":"2018","unstructured":"P\u00e9rez MJ, Jara C, Quintanilla RA (2018) Contribution of tau pathology to mitochondrial impairment in neurodegeneration. Front NeuroSci 12:441","journal-title":"Front NeuroSci"},{"key":"2328_CR152","doi-asserted-by":"publisher","first-page":"e102345","DOI":"10.15252\/embj.2019102345","volume":"38","author":"F Peters","year":"2019","unstructured":"Peters F, Salihoglu H, Pratsch K, Herzog E, Pigoni M, Sgobio C, Lichtenthaler SF, Neumann U, Herms J (2019) Tau deletion reduces plaque-associated BACE 1 accumulation and decelerates plaque formation in a mouse model of Alzheimer\u2019s disease. EMBO J 38:e102345","journal-title":"EMBO J"},{"key":"2328_CR153","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/WCO.0000000000001035","volume":"35","author":"GC Petersen","year":"2022","unstructured":"Petersen GC, Roytman M, Chiang GC, Li Y, Gordon ML, Franceschi AM (2022) Overview of tau PET molecular imaging. Curr Opin Neurol 35:230\u2013239","journal-title":"Curr Opin Neurol"},{"key":"2328_CR154","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/hmg\/ddh083","volume":"13","author":"L Petrucelli","year":"2004","unstructured":"Petrucelli L, Dickson D, Kehoe K, Taylor J, Snyder H, Grover A, De Lucia M, Mcgowan E, Lewis J, Prihar G (2004) CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum Mol Genet 13:703\u2013714","journal-title":"Hum Mol Genet"},{"key":"2328_CR155","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1016\/j.celrep.2019.11.044","volume":"29","author":"EK Pickett","year":"2019","unstructured":"Pickett EK, Herrmann AG, Mcqueen J, Abt K, Dando O, Tulloch J, Jain P, Dunnett S, Sohrabi S, Fjeldstad MP (2019) Amyloid beta and tau cooperate to cause reversible behavioral and transcriptional deficits in a model of Alzheimer\u2019s disease. Cell Rep 29:3592\u20133604 e5","journal-title":"Cell Rep"},{"key":"2328_CR156","doi-asserted-by":"publisher","first-page":"34298","DOI":"10.1074\/jbc.M102780200","volume":"276","author":"E Planel","year":"2001","unstructured":"Planel E, Yasutake K, Fujita SC, Ishiguro K (2001) Inhibition of protein phosphatase 2A overrides tau protein kinase I\/glycogen synthase kinase 3\u03b2 and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. J Biol Chem 276:34298\u201334306","journal-title":"J Biol Chem"},{"key":"2328_CR157","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.1074\/jbc.M110.178905","volume":"286","author":"HY Qureshi","year":"2011","unstructured":"Qureshi HY, Paudel HK (2011) Parkinsonian neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) and \u03b1-synuclein mutations promote tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro. J Biol Chem 286:5055\u20135068","journal-title":"J Biol Chem"},{"key":"2328_CR158","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.3390\/ijms232112841","volume":"23","author":"P Rawat","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH (2022) Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci 23:12841","journal-title":"Int J Mol Sci"},{"key":"2328_CR159","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/cells8050488","volume":"8","author":"PH Reddy","year":"2019","unstructured":"Reddy PH, Oliver DM (2019) Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer\u2019s disease. Cells 8:488","journal-title":"Cells"},{"key":"2328_CR160","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.brainres.2008.02.107","volume":"1214","author":"K Rezai-Zadeh","year":"2008","unstructured":"Rezai-Zadeh K, Arendash GW, Hou H, Fernandez F, Jensen M, Runfeldt M, Shytle RD, Tan J (2008) Green tea epigallocatechin-3-gallate (EGCG) reduces \u03b2-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res 1214:177\u2013187","journal-title":"Brain Res"},{"key":"2328_CR162","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-180740","volume":"68","author":"AR Roda","year":"2019","unstructured":"Roda AR, Montoliu-Gaya L, Villegas S (2019) The role of apolipoprotein E isoforms in Alzheimer\u2019s disease. J Alzheimers Dis 68:459\u2013471","journal-title":"J Alzheimers Dis"},{"key":"2328_CR161","doi-asserted-by":"publisher","first-page":"6630","DOI":"10.3390\/ijms21186630","volume":"21","author":"AR Roda","year":"2020","unstructured":"Roda AR, Montoliu-Gaya L, Serra-Mir G, Villegas S (2020) Both amyloid-\u03b2 peptide and tau protein are affected by an anti-amyloid-\u03b2 antibody fragment in elderly 3xTg-AD mice. Int J Mol Sci 21:6630","journal-title":"Int J Mol Sci"},{"key":"2328_CR163","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.4103\/1673-5374.332127","volume":"17","author":"AR Roda","year":"2022","unstructured":"Roda AR, Serra-Mir G, Montoliu-Gaya L, Tiessler L, Villegas S (2022) Amyloid-beta peptide and tau protein crosstalk in Alzheimer\u2019s disease. Neural regeneration Res 17:1666\u20131674","journal-title":"Neural regeneration Res"},{"key":"2328_CR164","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1016\/j.neurobiolaging.2013.03.015","volume":"34","author":"T Rodr\u00edguez-Mart\u00edn","year":"2013","unstructured":"Rodr\u00edguez-Mart\u00edn T, Cuchillo-Ib\u00e1\u00f1ez I, Noble W, Nyenya F, Anderton BH, Hanger DP (2013) Tau phosphorylation affects its axonal transport and degradation. Neurobiol Aging 34:2146\u20132157","journal-title":"Neurobiol Aging"},{"key":"2328_CR165","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1039\/C3NP70092E","volume":"31","author":"CC Rohena","year":"2014","unstructured":"Rohena CC, Mooberry SL (2014) Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities. Nat Prod Rep 31:335\u2013355","journal-title":"Nat Prod Rep"},{"key":"2328_CR166","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1093\/hmg\/ddu011","volume":"23","author":"B Roy","year":"2014","unstructured":"Roy B, Jackson GR (2014) Interactions between Tau and \u03b1-synuclein augment neurotoxicity in a Drosophila model of Parkinson\u2019s disease. Hum Mol Genet 23:3008\u20133023","journal-title":"Hum Mol Genet"},{"key":"2328_CR167","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nature05291","volume":"443","author":"DC Rubinsztein","year":"2006","unstructured":"Rubinsztein DC (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443:780\u2013786","journal-title":"Nature"},{"key":"2328_CR168","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nn.2858","volume":"14","author":"T Saito","year":"2011","unstructured":"Saito T, Suemoto T, Brouwers N, Sleegers K, Funamoto S, Mihira N, Matsuba Y, Yamada K, Nilsson P, Takano J (2011) Potent amyloidogenicity and pathogenicity of A\u03b243. Nat Neurosci 14:1023\u20131032","journal-title":"Nat Neurosci"},{"key":"2328_CR169","doi-asserted-by":"publisher","first-page":"725241","DOI":"10.3389\/fcell.2021.725241","volume":"9","author":"CA Sallaberry","year":"2021","unstructured":"Sallaberry CA, Voss BJ, Majewski J, Biernat J, Mandelkow E, Chi EY, Zanden V, C. M (2021) Tau and membranes: interactions that promote folding and condensation. Front cell Dev biology 9:725241","journal-title":"Front cell Dev biology"},{"key":"2328_CR170","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","volume":"82","author":"DW Sanders","year":"2014","unstructured":"Sanders DW, Kaufman SK, Devos SL, Sharma AM, Mirbaha H, Li A, Barker SJ, Foley AC, Thorpe JR, Serpell LC (2014) Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82:1271\u20131288","journal-title":"Neuron"},{"key":"2328_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-020-00635-0","volume":"12","author":"TM Satir","year":"2020","unstructured":"Satir TM, Agholme L, Karlsson A, Karlsson M, Karila P, Illes S, Bergstr\u00f6m P, Zetterberg H (2020) Partial reduction of amyloid \u03b2 production by \u03b2-secretase inhibitors does not decrease synaptic transmission. Alzheimers Res Ther 12:1\u20139","journal-title":"Alzheimers Res Ther"},{"key":"2328_CR172","doi-asserted-by":"crossref","unstructured":"Schmauck-Medina T, Patrick-Brown TD, Zhang S-Q, Gilbert A, Fang EF (2022) Molecular linkages among A\u03b2, tau, impaired mitophagy, and mitochondrial dysfunction in Alzheimer\u2019s disease. Autophagy Dysfunction in Alzheimer\u2019s Disease and Dementia. Elsevier","DOI":"10.1016\/B978-0-323-89906-2.00007-1"},{"key":"2328_CR173","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/ijms19040998","volume":"19","author":"\u00c1 Sebasti\u00e1n-Serrano","year":"2018","unstructured":"Sebasti\u00e1n-Serrano \u00c1, De Diego-Garc\u00eda L, D\u00edaz-Hern\u00e1ndez M (2018) The neurotoxic role of extracellular tau protein. Int J Mol Sci 19:998","journal-title":"Int J Mol Sci"},{"key":"2328_CR174","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev.neuro.26.041002.131334","volume":"26","author":"D Selkoe","year":"2003","unstructured":"Selkoe D, Kopan R (2003) Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci 26:565\u2013597","journal-title":"Annu Rev Neurosci"},{"key":"2328_CR175","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y (2016) The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature 537:50\u201356","journal-title":"Nature"},{"key":"2328_CR176","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1007\/s11064-024-04178-w","volume":"49","author":"L Sheng","year":"2024","unstructured":"Sheng L, Bhalla R (2024) Biomarkers and target-specific small-molecule drugs in Alzheimer\u2019s diagnostic and therapeutic research: from amyloidosis to tauopathy. Neurochem Res 49:2273\u20132302","journal-title":"Neurochem Res"},{"key":"2328_CR177","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/ijms25020831","volume":"25","author":"H Shi","year":"2024","unstructured":"Shi H, Zhao Y (2024) Modulation of Tau Pathology in Alzheimer\u2019s Disease by Dietary Bioactive Compounds. Int J Mol Sci 25:831","journal-title":"Int J Mol Sci"},{"key":"2328_CR178","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13195-022-01150-0","volume":"14","author":"KH Shim","year":"2022","unstructured":"Shim KH, Kang MJ, Youn YC, An SSA, Kim S (2022) Alpha-synuclein: a pathological factor with A\u03b2 and tau and biomarker in Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther 14:201","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"2328_CR179","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.1074\/jbc.M305838200","volume":"279","author":"H Shimura","year":"2004","unstructured":"Shimura H, Schwartz D, Gygi SP, Kosik KS (2004) CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J Biol Chem 279:4869\u20134876","journal-title":"J Biol Chem"},{"key":"2328_CR180","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1186\/s12967-025-06572-6","volume":"23","author":"CJ Siebrand","year":"2025","unstructured":"Siebrand CJ, Bergo NJ, Lee S, Andersen JK, Walton CC (2025) Chimeric antigen receptors discriminate between tau and distinct amyloid-beta species. J Translational Med 23:605","journal-title":"J Translational Med"},{"key":"2328_CR181","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.4103\/1673-5374.385288","volume":"19","author":"H Singh","year":"2024","unstructured":"Singh H, Das A, Khan MM, Pourmotabbed T (2024) New insights into the therapeutic approaches for the treatment of tauopathies. Neural Regeneration Res 19:1020\u20131026","journal-title":"Neural Regeneration Res"},{"key":"2328_CR182","doi-asserted-by":"publisher","first-page":"9207","DOI":"10.3390\/ijms22179207","volume":"22","author":"J Sinsky","year":"2021","unstructured":"Sinsky J, Pichlerova K, Hanes J (2021) Tau protein interaction partners and their roles in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci 22:9207","journal-title":"Int J Mol Sci"},{"key":"2328_CR183","doi-asserted-by":"publisher","first-page":"903119","DOI":"10.3389\/fphar.2022.903119","volume":"13","author":"L Sivanantharajah","year":"2022","unstructured":"Sivanantharajah L, Mudher A (2022) Curcumin as a holistic treatment for tau pathology. Front Pharmacol 13:903119","journal-title":"Front Pharmacol"},{"key":"2328_CR184","doi-asserted-by":"publisher","first-page":"6721","DOI":"10.1093\/hmg\/ddv377","volume":"24","author":"PY Smith","year":"2015","unstructured":"Smith PY, Hernandez-Rapp J, Jolivette F, Lecours C, Bisht K, Goupil C, Dorval V, Parsi S, Morin F, Planel E (2015) miR-132\/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. Hum Mol Genet 24:6721\u20136735","journal-title":"Hum Mol Genet"},{"key":"2328_CR185","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.neuron.2012.02.006","volume":"73","author":"C Soto","year":"2012","unstructured":"Soto C (2012) In vivo spreading of tau pathology. Neuron 73:621\u2013623","journal-title":"Neuron"},{"key":"2328_CR186","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ana.25395","volume":"85","author":"RA Sperling","year":"2019","unstructured":"Sperling RA, Mormino EC, Schultz AP, Betensky RA, Papp KV, Amariglio RE, Hanseeuw BJ, Buckley R, Chhatwal J, Hedden T (2019) The impact of amyloid-beta and tau on prospective cognitive decline in older individuals. Ann Neurol 85:181\u2013193","journal-title":"Ann Neurol"},{"key":"2328_CR187","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","volume":"12","author":"MG Spillantini","year":"2013","unstructured":"Spillantini MG, Goedert M (2013) Tau pathology and neurodegeneration. Lancet Neurol 12:609\u2013622","journal-title":"Lancet Neurol"},{"key":"2328_CR188","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tins.2008.11.007","volume":"32","author":"TL Spires-Jones","year":"2009","unstructured":"Spires-Jones TL, Stoothoff WH, De Calignon A, Jones PB, Hyman BT (2009) Tau pathophysiology in neurodegeneration: a tangled issue. Trends Neurosci 32:150\u2013159","journal-title":"Trends Neurosci"},{"key":"2328_CR189","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1083\/jcb.200108057","volume":"156","author":"K Stamer","year":"2002","unstructured":"Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow E-M (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156:1051\u20131063","journal-title":"J Cell Biol"},{"key":"2328_CR190","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.3390\/ijms21176344","volume":"21","author":"L Szabo","year":"2020","unstructured":"Szabo L, Eckert A, Grimm A (2020) Insights into disease-associated tau impact on mitochondria. Int J Mol Sci 21:6344","journal-title":"Int J Mol Sci"},{"key":"2328_CR191","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12951-024-02526-0","volume":"22","author":"A Tapia-Arellano","year":"2024","unstructured":"Tapia-Arellano A, Cabrera P, Cort\u00e9s-Adasme E, Riveros A, Hassan N, Kogan MJ (2024) Tau-and \u03b1-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases. J Nanobiotechnol 22:248","journal-title":"J Nanobiotechnol"},{"key":"2328_CR192","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1038\/s41598-022-06846-9","volume":"12","author":"L Torres-Garcia","year":"2022","unstructured":"Torres-Garcia L, Domingues P, Brandi JM, Haikal E, Mudannayake C, Br\u00e1s JM, Gerhardt IC, Li E, Svanbergsson W, Outeiro A, T. F (2022) Monitoring the interactions between alpha-synuclein and Tau in vitro and in vivo using bimolecular fluorescence complementation. Sci Rep 12:2987","journal-title":"Sci Rep"},{"key":"2328_CR193","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nn.3178","volume":"15","author":"JW Um","year":"2012","unstructured":"Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM (2012) Alzheimer amyloid-\u03b2 oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci 15:1227\u20131235","journal-title":"Nat Neurosci"},{"key":"2328_CR194","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.3390\/ijms21145030","volume":"21","author":"E Vacchi","year":"2020","unstructured":"Vacchi E, Kaelin-Lang A, Melli G (2020) Tau and alpha synuclein synergistic effect in neurodegenerative diseases: When the periphery is the core. Int J Mol Sci 21:5030","journal-title":"Int J Mol Sci"},{"key":"2328_CR195","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.biopsych.2017.08.010","volume":"83","author":"CH Van Dyck","year":"2018","unstructured":"Van Dyck CH (2018) Anti-amyloid-\u03b2 monoclonal antibodies for Alzheimer\u2019s disease: pitfalls and promise. Biol Psychiatry 83:311\u2013319","journal-title":"Biol Psychiatry"},{"key":"2328_CR196","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","volume":"125","author":"J Wagner","year":"2013","unstructured":"Wagner J, Ryazanov S, Leonov A, Levin J, Shi S, Schmidt F, Prix C, Pan-Montojo F, Bertsch U, Mitteregger-Kretzschmar G (2013) Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease. Acta Neuropathol 125:795\u2013813","journal-title":"Acta Neuropathol"},{"key":"2328_CR197","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-071714-033828","volume":"38","author":"LC Walker","year":"2015","unstructured":"Walker LC, Jucker M (2015) Neurodegenerative diseases: expanding the prion concept. Annu Rev Neurosci 38:87\u2013103","journal-title":"Annu Rev Neurosci"},{"key":"2328_CR198","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.conb.2020.02.003","volume":"61","author":"DM Walsh","year":"2020","unstructured":"Walsh DM, Selkoe DJ (2020) Amyloid \u03b2-protein and beyond: the path forward in Alzheimer\u2019s disease. Curr Opin Neurobiol 61:116\u2013124","journal-title":"Curr Opin Neurobiol"},{"key":"2328_CR202","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1042\/BST20120071","volume":"40","author":"Y Wang","year":"2012","unstructured":"Wang Y, Mandelkow E (2012) Degradation of tau protein by autophagy and proteasomal pathways. Biochem Soc Trans 40:644\u2013652","journal-title":"Biochem Soc Trans"},{"key":"2328_CR203","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17:22\u201335","journal-title":"Nat Rev Neurosci"},{"key":"2328_CR200","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1006\/bbrc.1996.0278","volume":"219","author":"X Wang","year":"1996","unstructured":"Wang X, An S, Wu JM (1996) Specific processing of native and phosphorylated \u03c4 protein by proteases. Biochem Biophys Res Commun 219:591\u2013597","journal-title":"Biochem Biophys Res Commun"},{"key":"2328_CR201","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","volume":"1842","author":"X Wang","year":"2014","unstructured":"Wang X, Wang W, Li L, Perry G, Lee H-G, Zhu X (2014) Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease. Biochim Biophys Acta (BBA) Mol Basis Dis 1842:1240\u20131247","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"key":"2328_CR199","doi-asserted-by":"publisher","first-page":"5279","DOI":"10.7150\/thno.55680","volume":"11","author":"W Wang","year":"2021","unstructured":"Wang W, Zhou Q, Jiang T, Li S, Ye J, Zheng J, Wang X, Liu Y, Deng M, Ke D (2021) A novel small-molecule PROTAC selectively promotes tau clearance to improve cognitive functions in Alzheimer-like models. Theranostics 11:5279","journal-title":"Theranostics"},{"key":"2328_CR204","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ijbiomac.2021.03.113","volume":"181","author":"C Wells","year":"2021","unstructured":"Wells C, Brennan S, Keon M, Ooi L (2021) The role of amyloid oligomers in neurodegenerative pathologies. Int J Biol Macromol 181:582\u2013604","journal-title":"Int J Biol Macromol"},{"key":"2328_CR205","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","volume":"183","author":"H Wesseling","year":"2020","unstructured":"Wesseling H, Mair W, Kumar M, Schlaffner CN, Tang S, Beerepoot P, Fatou B, Guise AJ, Cheng L, Takeda S (2020) Tau PTM profiles identify patient heterogeneity and stages of Alzheimer\u2019s disease. Cell 183:1699\u20131713 e13","journal-title":"Cell"},{"key":"2328_CR206","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.2174\/1389450115666140804124808","volume":"16","author":"J Wolfram","year":"2015","unstructured":"Wolfram J, Zhu M, Yang Y, Shen J, Gentile E, Paolino D, Fresta M, Nie G, Chen C, Shen H (2015) Safety of nanoparticles in medicine. Curr Drug Targets 16:1671\u20131681","journal-title":"Curr Drug Targets"},{"key":"2328_CR207","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1074\/jbc.M112.394528","volume":"288","author":"JW Wu","year":"2013","unstructured":"Wu JW, Herman M, Liu L, Simoes S, Acker CM, Figueroa H, Steinberg JI, Margittai M, Kayed R, Zurzolo C (2013) Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons. J Biol Chem 288:1856\u20131870","journal-title":"J Biol Chem"},{"key":"2328_CR208","doi-asserted-by":"publisher","first-page":"101388","DOI":"10.1016\/j.nantod.2022.101388","volume":"43","author":"L Xu","year":"2022","unstructured":"Xu L, Ding Y, Ma F, Chen Y, Chen G, Zhu L, Long J, Ma R, Liu Y, Liu J (2022) Engineering a pathological tau-targeted nanochaperone for selective and synergetic inhibition of tau pathology in Alzheimer\u2019s disease. Nano Today 43:101388","journal-title":"Nano Today"},{"key":"2328_CR209","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3389\/fnins.2017.00667","volume":"11","author":"K Yamada","year":"2017","unstructured":"Yamada K (2017a) Extracellular tau and its potential role in the propagation of tau pathology. Front NeuroSci 11:667","journal-title":"Front NeuroSci"},{"key":"2328_CR210","doi-asserted-by":"publisher","first-page":"314325","DOI":"10.3389\/fnins.2017.00667","volume":"11","author":"K Yamada","year":"2017","unstructured":"Yamada K (2017b) Extracellular tau and its potential role in the propagation of tau pathology. Front NeuroSci 11:314325","journal-title":"Front NeuroSci"},{"key":"2328_CR211","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","volume":"80","author":"K Yanamandra","year":"2013","unstructured":"Yanamandra K, Kfoury N, Jiang H, Mahan TE, Ma S, Maloney SE, Wozniak DF, Diamond MI, Holtzman DM (2013) Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron 80:402\u2013414","journal-title":"Neuron"},{"key":"2328_CR213","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1093\/hmg\/ddr576","volume":"21","author":"W Yu","year":"2012","unstructured":"Yu W, Polepalli J, Wagh D, Rajadas J, Malenka R, Lu B (2012) A critical role for the PAR-1\/MARK-tau axis in mediating the toxic effects of A\u03b2 on synapses and dendritic spines. Hum Mol Genet 21:1384\u20131390","journal-title":"Hum Mol Genet"},{"key":"2328_CR212","doi-asserted-by":"publisher","first-page":"100620074","DOI":"10.21037\/apm-21-825","volume":"10","author":"B Yu","year":"2021","unstructured":"Yu B, Shan Y, Ding J (2021) A literature review of MRI techniques used to detect amyloid-beta plaques in Alzheimer\u2019s disease patients. Annals Palliat Med 10:100620074\u2013100610074","journal-title":"Annals Palliat Med"},{"key":"2328_CR215","doi-asserted-by":"publisher","first-page":"687973","DOI":"10.3389\/fnins.2021.687973","volume":"15","author":"M Zhang","year":"2021","unstructured":"Zhang M, Bian Z (2021) Alzheimer\u2019s disease and microRNA-132: a widespread pathological factor and potential therapeutic target. Front NeuroSci 15:687973","journal-title":"Front NeuroSci"},{"key":"2328_CR214","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1523\/JNEUROSCI.4922-11.2012","volume":"32","author":"B Zhang","year":"2012","unstructured":"Zhang B, Carroll J, Trojanowski JQ, Yao Y, Iba M, Potuzak JS, Hogan A-ML, Xie SX, Ballatore C, Smith AB (2012) The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J Neurosci 32:3601\u20133611","journal-title":"J Neurosci"},{"key":"2328_CR216","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/nm.3700","volume":"20","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Song M, Liu X, Kang SS, Kwon I-S, Duong DM, Seyfried NT, Hu WT, Liu Z, Wang J-Z (2014) Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer\u2019s disease. Nat Med 20:1254\u20131262","journal-title":"Nat Med"},{"key":"2328_CR217","doi-asserted-by":"publisher","first-page":"316523","DOI":"10.1155\/2013\/316523","volume":"2013","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Zhao B (2013) Oxidative stress and the pathogenesis of Alzheimer\u2019s disease. Oxid Med Cell Longev 2013:316523","journal-title":"Oxid Med Cell Longev"},{"key":"2328_CR218","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.biopsych.2018.04.022","volume":"84","author":"K Zhu","year":"2018","unstructured":"Zhu K, Peters F, Filser S, Herms J (2018) Consequences of pharmacological BACE inhibition on synaptic structure and function. Biol Psychiatry 84:478\u2013487","journal-title":"Biol Psychiatry"},{"key":"2328_CR219","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3390\/biom12121792","volume":"12","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Gandy L, Zhang F, Liu J, Wang C, Blair LJ, Linhardt RJ, Wang L (2022) Heparan sulfate proteoglycans in Tauopathy. Biomolecules 12:1792","journal-title":"Biomolecules"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02328-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02328-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02328-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:05:48Z","timestamp":1787929548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02328-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":219,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2328"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02328-w","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}